{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:47:30Z","timestamp":1747205250793,"version":"3.40.5"},"posted":{"date-parts":[[2024,5,15]]},"group-title":"In Review","reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,6]]},"abstract":"<title>Abstract<\/title><p>Several tools exist for assessing frailty in multiple myeloma (MM), but most are based on clinical trial datasets. In this study, we evaluate the prognostic impact of frailty based on the cumulative deficit frailty index (FI), and the prognostic impact of relationship and socioeconomic status (SES) in newly diagnosed MM patients. This is a retrospective study including 515 patients with MM seen at Mayo Clinic (Rochester, MN) at diagnosis between 2005\u20132018. The FI was calculated using patient-reported data on activities of daily living and comorbidity data. Items were scored as 0\/0.5\/1, with 1 indicating deficit. The FI was calculated by adding individual scores and dividing that by the number of non-missing items. Frailty was defined as FI\u2009\u2265\u20090.15; 61% were non-frail and 39% were frail. Frailty and non-married\/relationship status were associated with higher disease stage, decreased likelihood of early transplantation, and independently associated with decreased survival. SES was not independently associated with survival. Frail patients reported worse scores for fatigue, pain, and quality of life. In conclusion, a cumulative deficit FI was associated with higher symptom burden and decreased survival in a real-world cohort of newly diagnosed MM patients. Social support has prognostic value and should be assessed in clinical practice.<\/p>","DOI":"10.21203\/rs.3.rs-4373874\/v1","type":"posted-content","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:49:51Z","timestamp":1715788191000},"source":"Crossref","is-referenced-by-count":0,"title":["Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji","family":"Kumar","sequence":"first","affiliation":[{"name":"Mayo clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-1589","authenticated-orcid":false,"given":"Nadine","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Mayo clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Dizona","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Laplant","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menser","family":"Terri","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Aug","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Weivoda","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-9512","authenticated-orcid":false,"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-0203","authenticated-orcid":false,"given":"Francis","family":"Buadi","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma","family":"Warsame","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-9533","authenticated-orcid":false,"given":"Joselle","family":"Cook","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Lacy","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"HAYMAN","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5196","authenticated-orcid":false,"given":"Morie","family":"Gertz","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-1833","authenticated-orcid":false,"given":"S","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cancer Stat Facts: Myeloma. 2020 [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","article-title":"Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States","volume":"1","author":"Costa LJ","year":"2017","unstructured":"Costa LJ, Brill IK, Omel J, Godby K, Kumar SK, Brown EE. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 2017;1(4):282\u20137.","journal-title":"Blood Adv"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41375-021-01453-5","article-title":"Mortality trends in multiple myeloma after the introduction of novel therapies in the United States","volume":"36","author":"Binder M","year":"2022","unstructured":"Binder M, Nandakumar B, Rajkumar SV, Kapoor P, Buadi FK, Dingli D, et al. Mortality trends in multiple myeloma after the introduction of novel therapies in the United States. Leukemia. 2022;36(3):801\u20138.","journal-title":"Leukemia"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/10428194.2018.1509323","article-title":"Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients","volume":"60","author":"Gavriatopoulou M","year":"2019","unstructured":"Gavriatopoulou M, Fotiou D, Koloventzou U, Roussou M, Migkou M, Ntanasis-Stathopoulos I, et al. Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients. Leukemia & Lymphoma. 2019;60(3):619\u201328.","journal-title":"Leukemia & Lymphoma"},{"issue":"Supplement_1","key":"ref5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood-2019-121672","article-title":"Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort","volume":"134","author":"Mian HS","year":"2019","unstructured":"Mian HS, Kouroukis CT, Pond GR, Seow H, Sussman J. Undertreatment of Older Patients with Newly-Diagnosed Multiple Myeloma: Real World Evidence from a Canadian Registry Cohort. Blood. 2019;134(Supplement_1):268-.","journal-title":"Blood"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clml.2018.01.005","article-title":"Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies","volume":"18","author":"Fakhri B","year":"2018","unstructured":"Fakhri B, Fiala MA, Tuchman SA, Wildes TM. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. Clinical Lymphoma Myeloma and Leukemia. 2018;18(3):219\u201324.","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"issue":"9868","key":"ref7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg A","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362.","journal-title":"Lancet"},{"issue":"Supplement 1","key":"ref8","first-page":"3146","article-title":"Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87\/Nmsg-18 Study Group","volume":"130","author":"Stege CAM","year":"2017","unstructured":"Stege CAM, van der Holt B, Mellqvist U-H, Levin M-D, Salomo M, Abildgaard N, et al. Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87\/Nmsg-18 Study Group. Blood. 2017;130(Supplement 1):3146-.","journal-title":"Blood"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo A","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068\u201374.","journal-title":"Blood"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt M","year":"2017","unstructured":"Engelhardt M, Domm AS, Dold SM, Ihorst G, Reinhardt H, Zober A, et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica. 2017;102(5):910\u201321.","journal-title":"Haematologica"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2020.254235","article-title":"Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial","volume":"106","author":"Dold SM","year":"2021","unstructured":"Dold SM, M\u00f6ller MD, Ihorst G, Langer C, P\u00f6nisch W, M\u00fcgge LO, et al. Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial. Haematologica. 2021;106(3):875\u201380.","journal-title":"Haematologica"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"e154-e66","DOI":"10.1016\/S2352-3026(18)30220-5","article-title":"A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study","volume":"6","author":"Cook G","year":"2019","unstructured":"Cook G, Royle KL, Pawlyn C, Hockaday A, Shah V, Kaiser MF, et al. A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study. Lancet Haematol. 2019;6(3):e154-e66.","journal-title":"Lancet Haematol"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma","volume":"91","author":"Milani P","year":"2016","unstructured":"Milani P, Vincent Rajkumar S, Merlini G, Kumar S, Gertz MA, Palladini G, et al. N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma. Am J Hematol. 2016;91(11):1129\u201334.","journal-title":"Am J Hematol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41375-019-0539-0","article-title":"A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial","volume":"34","author":"Facon T","year":"2020","unstructured":"Facon T, Dimopoulos MA, Meuleman N, Belch A, Mohty M, Chen WM, et al. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial. Leukemia. 2020;34(1):224\u201333.","journal-title":"Leukemia"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41375-020-0713-4","article-title":"Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities","volume":"34","author":"Stege CAM","year":"2020","unstructured":"Stege CAM, van der Holt B, Dinmohamed AG, Sonneveld P, Levin MD, van de Donk N, et al. Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities. Leukemia. 2020;34(7):1964\u20136.","journal-title":"Leukemia"},{"issue":"13","key":"ref16","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo A","year":"2015","unstructured":"Palumbo A, Bringhen S, Mateos M-V, Larocca A, Facon T, Kumar SK, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125(13):2068\u201374.","journal-title":"Blood"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jgo.2013.07.010","article-title":"Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different","volume":"5","author":"Broderick JM","year":"2014","unstructured":"Broderick JM, Hussey J, Kennedy MJ, DM OD. Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different. J Geriatr Oncol. 2014;5(1):49\u201356.","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/cncr.23856","article-title":"Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer","volume":"113","author":"Schnadig ID","year":"2008","unstructured":"Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, et al. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer. 2008;113(8):2205\u201314.","journal-title":"Cancer"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle SD","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatrics. 2008;8(1):24.","journal-title":"BMC Geriatrics"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ahj.2013.07.008","article-title":"Measuring frailty in heart failure: A community perspective","volume":"166","author":"McNallan SM","year":"2013","unstructured":"McNallan SM, Chamberlain AM, Gerber Y, Singh M, Kane RL, Weston SA, et al. Measuring frailty in heart failure: A community perspective. American Heart Journal. 2013;166(4):768\u201374.","journal-title":"American Heart Journal"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2017.07.126","article-title":"Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer","volume":"147","author":"Kumar A","year":"2017","unstructured":"Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, et al. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer. Gynecol Oncol. 2017;147(1):104\u20139.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ygyno.2021.02.027","article-title":"A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy","volume":"161","author":"Mullen MM","year":"2021","unstructured":"Mullen MM, McKinnish TR, Fiala MA, Zamorano AS, Kuroki LM, Fuh KC, et al. A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy. Gynecologic Oncology. 2021;161(3):700\u20134.","journal-title":"Gynecologic Oncology"},{"key":"ref23","article-title":"Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma","volume":"2","author":"Mian HS","year":"2018","unstructured":"Mian HS, Wildes TM, Fiala MA. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma. JCO Clin Cancer Inform. 2018;2.","journal-title":"JCO Clin Cancer Inform"},{"issue":"31","key":"ref24","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","article-title":"Marital Status and Survival in Patients With Cancer","volume":"31","author":"Aizer AA","year":"2013","unstructured":"Aizer AA, Chen M-H, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, et al. Marital Status and Survival in Patients With Cancer. Journal of Clinical Oncology. 2013;31(31):3869\u201376.","journal-title":"Journal of Clinical Oncology"},{"issue":"37","key":"ref25","doi-asserted-by":"crossref","first-page":"62666","DOI":"10.18632\/oncotarget.16989","article-title":"Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study","volume":"8","author":"Zheng Z","year":"2017","unstructured":"Zheng Z, Zhu Y, Li X, Hu W, Jiang J. Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study. Oncotarget. 2017;8(37):62666\u201380.","journal-title":"Oncotarget"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/16078454.2022.2026027","article-title":"The effect of marital status on the survival of patients with multiple myeloma","volume":"27","author":"Tang L","year":"2022","unstructured":"Tang L, Pan Z, Zhang X. The effect of marital status on the survival of patients with multiple myeloma. Hematology. 2022;27(1):187\u201397.","journal-title":"Hematology"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clml.2021.02.001","article-title":"The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center","volume":"21","author":"Evans LA","year":"2021","unstructured":"Evans LA, Go R, Warsame R, Nandakumar B, Buadi FK, Dispenzieri A, et al. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center. Clin Lymphoma Myeloma Leuk. 2021;21(7):451\u2009\u2013\u200960.e2.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41408-022-00648-y","article-title":"Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients","volume":"12","author":"Obeng-Gyasi S","year":"2022","unstructured":"Obeng-Gyasi S, Graham N, Kumar S, Lee J-W, Jacobus S, Weiss M, et al. Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients. Blood Cancer Journal. 2022;12(4):53.","journal-title":"Blood Cancer Journal"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbmt.2016.03.011","article-title":"Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma","volume":"22","author":"Hong S","year":"2016","unstructured":"Hong S, Rybicki L, Abounader D, Bolwell BJ, Dean R, Gerds AT, et al. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2016;22(6):1141\u20134.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11524-011-9572-7","article-title":"Development and Initial Testing of a New Socioeconomic Status Measure Based on Housing Data","volume":"88","author":"Juhn YJ","year":"2011","unstructured":"Juhn YJ, Beebe TJ, Finnie DM, Sloan J, Wheeler PH, Yawn B, et al. Development and Initial Testing of a New Socioeconomic Status Measure Based on Housing Data. Journal of Urban Health. 2011;88(5):933\u201344.","journal-title":"Journal of Urban Health"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajh.24676","article-title":"Hematology patient reported symptom screen to assess quality of life for AL amyloidosis","volume":"92","author":"Warsame R","year":"2017","unstructured":"Warsame R, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, et al. Hematology patient reported symptom screen to assess quality of life for AL amyloidosis. American Journal of Hematology. 2017;92(5):435\u201340.","journal-title":"American Journal of Hematology"},{"issue":"15","key":"ref32","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International Staging System for Multiple Myeloma","volume":"23","author":"Greipp PR","year":"2005","unstructured":"Greipp PR, Miguel JS, Durie BGM, Crowley JJ, Barlogie B, Blad\u00e9 J, et al. International Staging System for Multiple Myeloma. Journal of Clinical Oncology. 2005;23(15):3412\u201320.","journal-title":"Journal of Clinical Oncology"},{"issue":"26","key":"ref33","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","volume":"33","author":"Palumbo A","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. Journal of Clinical Oncology. 2015;33(26):2863\u20139.","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca R","year":"2003","unstructured":"Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, et al. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood. 2003;101(11):4569\u201375.","journal-title":"Blood"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41408-022-00611-x","article-title":"A simple additive staging system for newly diagnosed multiple myeloma","volume":"12","author":"Abdallah NH","year":"2022","unstructured":"Abdallah NH, Binder M, Rajkumar SV, Greipp PT, Kapoor P, Dispenzieri A, et al. A simple additive staging system for newly diagnosed multiple myeloma. Blood Cancer Journal. 2022;12(1):21.","journal-title":"Blood Cancer Journal"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"e328-e46","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar S","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328-e46.","journal-title":"Lancet Oncol"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/s41375-021-01162-z","article-title":"Improving the identification of frail elderly newly diagnosed multiple myeloma patients","volume":"35","author":"Stege CAM","year":"2021","unstructured":"Stege CAM, Nasserinejad K, Klein SK, Timmers G-J, Hoogendoorn M, Ypma PF, et al. Improving the identification of frail elderly newly diagnosed multiple myeloma patients. Leukemia. 2021;35(9):2715\u20139.","journal-title":"Leukemia"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jgo.2018.10.010","article-title":"Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older","volume":"10","author":"Murillo A","year":"2019","unstructured":"Murillo A, Cronin AM, Laubach JP, Hshieh TT, Tanasijevic AM, Richardson PG, et al. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older. J Geriatr Oncol. 2019;10(3):486\u20139.","journal-title":"J Geriatr Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/CCI.19.00094","article-title":"Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans","volume":"4","author":"Patel BG","year":"2020","unstructured":"Patel BG, Luo S, Wildes TM, Sanfilippo KM. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans. JCO Clin Cancer Inform. 2020;4:117\u201327.","journal-title":"JCO Clin Cancer Inform"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-023-00843-5","article-title":"Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study","volume":"13","author":"Mian H","year":"2023","unstructured":"Mian H, Wildes TM, Vij R, Pianko MJ, Major A, Fiala MA. Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study. Blood Cancer J. 2023;13(1):76.","journal-title":"Blood Cancer J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2147\/CIA.S196087","article-title":"Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide","volume":"15","author":"Schoenbeck KL","year":"2020","unstructured":"Schoenbeck KL, Wildes TM. Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide. Clin Interv Aging. 2020;15:619\u201333.","journal-title":"Clin Interv Aging"},{"issue":"Supplement 1","key":"ref42","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1182\/blood-2021-148191","article-title":"Lenalidomide Dosing and Outcomes in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database","volume":"138","author":"Mian HS","year":"2021","unstructured":"Mian HS, Leblanc R, Louzada ML, Masih-Khan E, McCurdy A, Venner CP, et al. Lenalidomide Dosing and Outcomes in Transplant-Ineligible Patients with Newly-Diagnosed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database. Blood. 2021;138(Supplement 1):4721-.","journal-title":"Blood"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1002\/cam4.5245","article-title":"Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database","volume":"12","author":"Mian H","year":"2023","unstructured":"Mian H, LeBlanc R, Louzada M, Masih-Khan E, McCurdy A, Venner CP, et al. Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database. Cancer Medicine. 2023;12(4):4357\u201362.","journal-title":"Cancer Medicine"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00277-020-04023-4","article-title":"The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma","volume":"99","author":"Merz M","year":"2020","unstructured":"Merz M, Dechow T, Scheytt M, Schmidt C, Hackanson B, Knop S. The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma. Annals of Hematology. 2020;99(8):1709\u201325.","journal-title":"Annals of Hematology"},{"issue":"Supplement 1","key":"ref45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2020-133369","article-title":"Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes","volume":"136","author":"Mian HS","year":"2020","unstructured":"Mian HS, Pond GR, Sivapathasundaram B, Wildes TM, Sussman J, Seow H. Symptom Burden in Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma: A Population-Based Study of Patient-Reported Outcomes. Blood. 2020;136(Supplement 1):30\u20131.","journal-title":"Blood"},{"issue":"Supplement 1","key":"ref46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood-2021-146862","article-title":"Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma","volume":"138","author":"Mian HS","year":"2021","unstructured":"Mian HS, Sutradhar R, Pond GR, Sivapathasundaram B, D'Souza A, Wildes TM, et al. Is Symptom Burden Associated with Health Care Utilization: A Longitudinal Population-Based Cohort Study of Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma. Blood. 2021;138(Supplement 1):116-.","journal-title":"Blood"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"101589","DOI":"10.1016\/j.jgo.2023.101589","article-title":"Marital status, frailty, and survival in older adults with blood cancer","volume":"14","author":"Avila J","year":"2023","unstructured":"Avila J, DuMontier C, Cernik C, Uno H, Hshieh T, Ho K, et al. Marital status, frailty, and survival in older adults with blood cancer. J Geriatr Oncol. 2023;14(8):101589.","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040590","article-title":"Socioeconomic Factors and Survival of Multiple Myeloma Patients","volume":"13","author":"Chamoun K","year":"2021","unstructured":"Chamoun K, Firoozmand A, Caimi P, Fu P, Cao S, Otegbeye F, et al. Socioeconomic Factors and Survival of Multiple Myeloma Patients. Cancers (Basel). 2021;13(4).","journal-title":"Cancers (Basel)"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4373874\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4373874\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T03:03:57Z","timestamp":1731985437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4373874\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":48,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4373874\/v1","relation":{},"subject":[],"published":{"date-parts":[[2024,5,15]]},"subtype":"preprint"}}